• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Fibromyalgia Treatment Market Research Report 2020

report cover
  • 29 October 2020
  • Healthcare
  • 123 Pages
  • Report Code: 24LS-21731
  • Formate :   
Download FREE Report Sample Download PDF File

Fibromyalgia Treatment -MARKET ADVISORY SERVICES

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Fibromyalgia Treatment market is segmented into
Antidepressants
Anticonvulsants
Muscle Relaxants
Narcotic Analgesics
Non-narcotic Analgesics

Segment by Application
Hospitals Pharmacies
Clinic Pharmacy
Retail Drug Stores
Online Pharmacies

Global Fibromyalgia Treatment Market: Regional Analysis
The Fibromyalgia Treatment market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Fibromyalgia Treatment market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Global Fibromyalgia Treatment Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Fibromyalgia Treatment market include:
Eli Lilly and Company
Pfizer
Novartis AG
Allergan
Aptinyx
Prismic Pharmaceuticals
Innovative Med Concepts
Intec Pharma Ltd.
Astellas Pharma
Savella
Sun Pharmaceutical Industries
Mylan NV
Teva Pharmaceutical Industries
Daiichi Sankyo
Forest Pharmaceuticals
Meiji Seika Pharma
Tonix Pharmaceuticals
Theravance Biopharma
1 Fibromyalgia Treatment Market Overview
1.1 Product Overview and Scope of Fibromyalgia Treatment
1.2 Fibromyalgia Treatment Segment by Type
1.2.1 Global Fibromyalgia Treatment Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Antidepressants
1.2.3 Anticonvulsants
1.2.4 Muscle Relaxants
1.2.5 Narcotic Analgesics
1.2.6 Non-narcotic Analgesics
1.3 Fibromyalgia Treatment Segment by Application
1.3.1 Fibromyalgia Treatment Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospitals Pharmacies
1.3.3 Clinic Pharmacy
1.3.4 Retail Drug Stores
1.3.5 Online Pharmacies
1.4 Global Fibromyalgia Treatment Market Size Estimates and Forecasts
1.4.1 Global Fibromyalgia Treatment Revenue 2015-2026
1.4.2 Global Fibromyalgia Treatment Sales 2015-2026
1.4.3 Fibromyalgia Treatment Market Size by Region: 2020 Versus 2026
1.5 Fibromyalgia Treatment Industry
1.6 Fibromyalgia Treatment Market Trends

2 Global Fibromyalgia Treatment Market Competition by Manufacturers
2.1 Global Fibromyalgia Treatment Sales Market Share by Manufacturers (2015-2020)
2.2 Global Fibromyalgia Treatment Revenue Share by Manufacturers (2015-2020)
2.3 Global Fibromyalgia Treatment Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Fibromyalgia Treatment Manufacturing Sites, Area Served, Product Type
2.5 Fibromyalgia Treatment Market Competitive Situation and Trends
2.5.1 Fibromyalgia Treatment Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Fibromyalgia Treatment Players (Opinion Leaders)

3 Fibromyalgia Treatment Retrospective Market Scenario by Region
3.1 Global Fibromyalgia Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Fibromyalgia Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Fibromyalgia Treatment Market Facts & Figures by Country
3.3.1 North America Fibromyalgia Treatment Sales by Country
3.3.2 North America Fibromyalgia Treatment Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Fibromyalgia Treatment Market Facts & Figures by Country
3.4.1 Europe Fibromyalgia Treatment Sales by Country
3.4.2 Europe Fibromyalgia Treatment Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Fibromyalgia Treatment Market Facts & Figures by Region
3.5.1 Asia Pacific Fibromyalgia Treatment Sales by Region
3.5.2 Asia Pacific Fibromyalgia Treatment Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Fibromyalgia Treatment Market Facts & Figures by Country
3.6.1 Latin America Fibromyalgia Treatment Sales by Country
3.6.2 Latin America Fibromyalgia Treatment Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Fibromyalgia Treatment Market Facts & Figures by Country
3.7.1 Middle East and Africa Fibromyalgia Treatment Sales by Country
3.7.2 Middle East and Africa Fibromyalgia Treatment Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Fibromyalgia Treatment Historic Market Analysis by Type
4.1 Global Fibromyalgia Treatment Sales Market Share by Type (2015-2020)
4.2 Global Fibromyalgia Treatment Revenue Market Share by Type (2015-2020)
4.3 Global Fibromyalgia Treatment Price Market Share by Type (2015-2020)
4.4 Global Fibromyalgia Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Fibromyalgia Treatment Historic Market Analysis by Application
5.1 Global Fibromyalgia Treatment Sales Market Share by Application (2015-2020)
5.2 Global Fibromyalgia Treatment Revenue Market Share by Application (2015-2020)
5.3 Global Fibromyalgia Treatment Price by Application (2015-2020)

6 Company Profiles and Key Figures in Fibromyalgia Treatment Business
6.1 Eli Lilly and Company
6.1.1 Corporation Information
6.1.2 Eli Lilly and Company Description, Business Overview and Total Revenue
6.1.3 Eli Lilly and Company Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Eli Lilly and Company Products Offered
6.1.5 Eli Lilly and Company Recent Development
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description, Business Overview and Total Revenue
6.2.3 Pfizer Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Pfizer Products Offered
6.2.5 Pfizer Recent Development
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description, Business Overview and Total Revenue
6.3.3 Novartis AG Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Novartis AG Products Offered
6.3.5 Novartis AG Recent Development
6.4 Allergan
6.4.1 Allergan Corporation Information
6.4.2 Allergan Description, Business Overview and Total Revenue
6.4.3 Allergan Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Allergan Products Offered
6.4.5 Allergan Recent Development
6.5 Aptinyx
6.5.1 Aptinyx Corporation Information
6.5.2 Aptinyx Description, Business Overview and Total Revenue
6.5.3 Aptinyx Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Aptinyx Products Offered
6.5.5 Aptinyx Recent Development
6.6 Prismic Pharmaceuticals
6.6.1 Prismic Pharmaceuticals Corporation Information
6.6.2 Prismic Pharmaceuticals Description, Business Overview and Total Revenue
6.6.3 Prismic Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Prismic Pharmaceuticals Products Offered
6.6.5 Prismic Pharmaceuticals Recent Development
6.7 Innovative Med Concepts
6.6.1 Innovative Med Concepts Corporation Information
6.6.2 Innovative Med Concepts Description, Business Overview and Total Revenue
6.6.3 Innovative Med Concepts Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Innovative Med Concepts Products Offered
6.7.5 Innovative Med Concepts Recent Development
6.8 Intec Pharma Ltd.
6.8.1 Intec Pharma Ltd. Corporation Information
6.8.2 Intec Pharma Ltd. Description, Business Overview and Total Revenue
6.8.3 Intec Pharma Ltd. Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Intec Pharma Ltd. Products Offered
6.8.5 Intec Pharma Ltd. Recent Development
6.9 Astellas Pharma
6.9.1 Astellas Pharma Corporation Information
6.9.2 Astellas Pharma Description, Business Overview and Total Revenue
6.9.3 Astellas Pharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Astellas Pharma Products Offered
6.9.5 Astellas Pharma Recent Development
6.10 Savella
6.10.1 Savella Corporation Information
6.10.2 Savella Description, Business Overview and Total Revenue
6.10.3 Savella Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Savella Products Offered
6.10.5 Savella Recent Development
6.11 Sun Pharmaceutical Industries
6.11.1 Sun Pharmaceutical Industries Corporation Information
6.11.2 Sun Pharmaceutical Industries Fibromyalgia Treatment Description, Business Overview and Total Revenue
6.11.3 Sun Pharmaceutical Industries Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Sun Pharmaceutical Industries Products Offered
6.11.5 Sun Pharmaceutical Industries Recent Development
6.12 Mylan NV
6.12.1 Mylan NV Corporation Information
6.12.2 Mylan NV Fibromyalgia Treatment Description, Business Overview and Total Revenue
6.12.3 Mylan NV Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Mylan NV Products Offered
6.12.5 Mylan NV Recent Development
6.13 Teva Pharmaceutical Industries
6.13.1 Teva Pharmaceutical Industries Corporation Information
6.13.2 Teva Pharmaceutical Industries Fibromyalgia Treatment Description, Business Overview and Total Revenue
6.13.3 Teva Pharmaceutical Industries Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Teva Pharmaceutical Industries Products Offered
6.13.5 Teva Pharmaceutical Industries Recent Development
6.14 Daiichi Sankyo
6.14.1 Daiichi Sankyo Corporation Information
6.14.2 Daiichi Sankyo Fibromyalgia Treatment Description, Business Overview and Total Revenue
6.14.3 Daiichi Sankyo Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Daiichi Sankyo Products Offered
6.14.5 Daiichi Sankyo Recent Development
6.15 Forest Pharmaceuticals
6.15.1 Forest Pharmaceuticals Corporation Information
6.15.2 Forest Pharmaceuticals Fibromyalgia Treatment Description, Business Overview and Total Revenue
6.15.3 Forest Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Forest Pharmaceuticals Products Offered
6.15.5 Forest Pharmaceuticals Recent Development
6.16 Meiji Seika Pharma
6.16.1 Meiji Seika Pharma Corporation Information
6.16.2 Meiji Seika Pharma Fibromyalgia Treatment Description, Business Overview and Total Revenue
6.16.3 Meiji Seika Pharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Meiji Seika Pharma Products Offered
6.16.5 Meiji Seika Pharma Recent Development
6.17 Tonix Pharmaceuticals
6.17.1 Tonix Pharmaceuticals Corporation Information
6.17.2 Tonix Pharmaceuticals Fibromyalgia Treatment Description, Business Overview and Total Revenue
6.17.3 Tonix Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Tonix Pharmaceuticals Products Offered
6.17.5 Tonix Pharmaceuticals Recent Development
6.18 Theravance Biopharma
6.18.1 Theravance Biopharma Corporation Information
6.18.2 Theravance Biopharma Fibromyalgia Treatment Description, Business Overview and Total Revenue
6.18.3 Theravance Biopharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Theravance Biopharma Products Offered
6.18.5 Theravance Biopharma Recent Development

7 Fibromyalgia Treatment Manufacturing Cost Analysis
7.1 Fibromyalgia Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Fibromyalgia Treatment
7.4 Fibromyalgia Treatment Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Fibromyalgia Treatment Distributors List
8.3 Fibromyalgia Treatment Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Fibromyalgia Treatment Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Fibromyalgia Treatment by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Fibromyalgia Treatment by Type (2021-2026)
10.2 Fibromyalgia Treatment Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Fibromyalgia Treatment by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Fibromyalgia Treatment by Application (2021-2026)
10.3 Fibromyalgia Treatment Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Fibromyalgia Treatment by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Fibromyalgia Treatment by Region (2021-2026)
10.4 North America Fibromyalgia Treatment Estimates and Projections (2021-2026)
10.5 Europe Fibromyalgia Treatment Estimates and Projections (2021-2026)
10.6 Asia Pacific Fibromyalgia Treatment Estimates and Projections (2021-2026)
10.7 Latin America Fibromyalgia Treatment Estimates and Projections (2021-2026)
10.8 Middle East and Africa Fibromyalgia Treatment Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables

Table 1. Global Fibromyalgia Treatment Sales (KG) Growth Rate Comparison by Type (2015-2026)

Table 2. Global Fibromyalgia Treatment Sales (KG) Comparison by Application: 2020 VS 2026

Table 3. Global Fibromyalgia Treatment Market Size by Type (KG) (US$ Million) (2020 VS 2026)

Table 4. Global Key Fibromyalgia Treatment Manufacturers Covered in This Study

Table 5. Global Fibromyalgia Treatment Sales (KG) by Manufacturers (2015-2020)

Table 6. Global Fibromyalgia Treatment Sales Share by Manufacturers (2015-2020)

Table 7. Global Fibromyalgia Treatment Revenue (Million USD) by Manufacturers (2015-2020)

Table 8. Global Fibromyalgia Treatment Revenue Share by Manufacturers (2015-2020)

Table 9. Global Market Fibromyalgia Treatment Average Price (USD/KG) of Key Manufacturers (2015-2020)

Table 10. Manufacturers Fibromyalgia Treatment Sales Sites and Area Served

Table 11. Manufacturers Fibromyalgia Treatment Product Types

Table 12. Global Fibromyalgia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 13. Global Fibromyalgia Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Treatment as of 2019)

Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 15. Main Points Interviewed from Key Fibromyalgia Treatment Players

Table 16. Global Fibromyalgia Treatment Sales (KG) by Region (2015-2020)

Table 17. Global Fibromyalgia Treatment Sales Market Share by Region (2015-2020)

Table 18. Global Fibromyalgia Treatment Revenue (Million US$) by Region (2015-2020)

Table 19. Global Fibromyalgia Treatment Revenue Market Share by Region (2015-2020)

Table 20. North America Fibromyalgia Treatment Sales by Country (2015-2020) (KG)

Table 21. North America Fibromyalgia Treatment Sales Market Share by Country (2015-2020)

Table 22. North America Fibromyalgia Treatment Revenue by Country (2015-2020) (US$ Million)

Table 23. North America Fibromyalgia Treatment Revenue Market Share by Country (2015-2020)

Table 24. Europe Fibromyalgia Treatment Sales by Country (2015-2020) (KG)

Table 25. Europe Fibromyalgia Treatment Sales Market Share by Country (2015-2020)

Table 26. Europe Fibromyalgia Treatment Revenue by Country (2015-2020) (US$ Million)

Table 27. Europe Fibromyalgia Treatment Revenue Market Share by Country (2015-2020)

Table 28. Asia Pacific Fibromyalgia Treatment Sales by Region (2015-2020) (KG)

Table 29. Asia Pacific Fibromyalgia Treatment Sales Market Share by Region (2015-2020)

Table 30. Asia Pacific Fibromyalgia Treatment Revenue by Region (2015-2020) (US$ Million)

Table 31. Asia Pacific Fibromyalgia Treatment Revenue Market Share by Region (2015-2020)

Table 32. Latin America Fibromyalgia Treatment Sales by Country (2015-2020) (KG)

Table 33. Latin America Fibromyalgia Treatment Sales Market Share by Country (2015-2020)

Table 34. Latin America Fibromyalgia Treatment Revenue by Country (2015-2020) (US$ Million)

Table 35. Latin America Fibromyalgia Treatment Revenue Market Share by Country (2015-2020)

Table 36. Middle East and Africa Fibromyalgia Treatment Sales by Country (2015-2020) (KG)

Table 37. Middle East and Africa Fibromyalgia Treatment Sales Market Share by Country (2015-2020)

Table 38. Middle East and Africa Fibromyalgia Treatment Revenue by Country (2015-2020) (US$ Million)

Table 39. Middle East and Africa Fibromyalgia Treatment Revenue Market Share by Country (2015-2020)

Table 40. Global Fibromyalgia Treatment Sales (KG) by Type (2015-2020)

Table 41. Global Fibromyalgia Treatment Sales Share by Type (2015-2020)

Table 42. Global Fibromyalgia Treatment Revenue (Million US$) by Type (2015-2020)

Table 43. Global Fibromyalgia Treatment Revenue Share by Type (2015-2020)

Table 44. Global Fibromyalgia Treatment Price (USD/KG) by Type (2015-2020)

Table 45. Global Fibromyalgia Treatment Sales (KG) by Application (2015-2020)

Table 46. Global Fibromyalgia Treatment Sales Market Share by Application (2015-2020)

Table 47. Global Fibromyalgia Treatment Sales Growth Rate by Application (2015-2020)

Table 48. Eli Lilly and Company Fibromyalgia Treatment Corporation Information

Table 49. Eli Lilly and Company Description and Business Overview

Table 50. Eli Lilly and Company Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 51. Eli Lilly and Company Main Product

Table 52. Eli Lilly and Company Recent Development

Table 53. Pfizer Fibromyalgia Treatment Corporation Information

Table 54. Pfizer Corporation Information

Table 55. Pfizer Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 56. Pfizer Main Product

Table 57. Pfizer Recent Development

Table 58. Novartis AG Fibromyalgia Treatment Corporation Information

Table 59. Novartis AG Corporation Information

Table 60. Novartis AG Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 61. Novartis AG Main Product

Table 62. Novartis AG Recent Development

Table 63. Allergan Fibromyalgia Treatment Corporation Information

Table 64. Allergan Corporation Information

Table 65. Allergan Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 66. Allergan Main Product

Table 67. Allergan Recent Development

Table 68. Aptinyx Fibromyalgia Treatment Corporation Information

Table 69. Aptinyx Corporation Information

Table 70. Aptinyx Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 71. Aptinyx Main Product

Table 72. Aptinyx Recent Development

Table 73. Prismic Pharmaceuticals Fibromyalgia Treatment Corporation Information

Table 74. Prismic Pharmaceuticals Corporation Information

Table 75. Prismic Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 76. Prismic Pharmaceuticals Main Product

Table 77. Prismic Pharmaceuticals Recent Development

Table 78. Innovative Med Concepts Fibromyalgia Treatment Corporation Information

Table 79. Innovative Med Concepts Corporation Information

Table 80. Innovative Med Concepts Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 81. Innovative Med Concepts Main Product

Table 82. Innovative Med Concepts Recent Development

Table 83. Intec Pharma Ltd. Fibromyalgia Treatment Corporation Information

Table 84. Intec Pharma Ltd. Corporation Information

Table 85. Intec Pharma Ltd. Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 86. Intec Pharma Ltd. Main Product

Table 87. Intec Pharma Ltd. Recent Development

Table 88. Astellas Pharma Fibromyalgia Treatment Corporation Information

Table 89. Astellas Pharma Corporation Information

Table 90. Astellas Pharma Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 91. Astellas Pharma Main Product

Table 92. Astellas Pharma Recent Development

Table 93. Savella Fibromyalgia Treatment Corporation Information

Table 94. Savella Corporation Information

Table 95. Savella Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 96. Savella Main Product

Table 97. Savella Recent Development

Table 98. Sun Pharmaceutical Industries Fibromyalgia Treatment Corporation Information

Table 99. Sun Pharmaceutical Industries Corporation Information

Table 100. Sun Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 101. Sun Pharmaceutical Industries Main Product

Table 102. Sun Pharmaceutical Industries Recent Development

Table 103. Mylan NV Fibromyalgia Treatment Corporation Information

Table 104. Mylan NV Corporation Information

Table 105. Mylan NV Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 106. Mylan NV Main Product

Table 107. Mylan NV Recent Development

Table 108. Teva Pharmaceutical Industries Fibromyalgia Treatment Corporation Information

Table 109. Teva Pharmaceutical Industries Corporation Information

Table 110. Teva Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 111. Teva Pharmaceutical Industries Main Product

Table 112. Teva Pharmaceutical Industries Recent Development

Table 113. Daiichi Sankyo Fibromyalgia Treatment Corporation Information

Table 114. Daiichi Sankyo Corporation Information

Table 115. Daiichi Sankyo Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 116. Daiichi Sankyo Main Product

Table 117. Daiichi Sankyo Recent Development

Table 118. Forest Pharmaceuticals Fibromyalgia Treatment Corporation Information

Table 119. Forest Pharmaceuticals Corporation Information

Table 120. Forest Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 121. Forest Pharmaceuticals Main Product

Table 122. Forest Pharmaceuticals Recent Development

Table 123. Meiji Seika Pharma Fibromyalgia Treatment Corporation Information

Table 124. Meiji Seika Pharma Corporation Information

Table 125. Meiji Seika Pharma Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 126. Meiji Seika Pharma Main Product

Table 127. Meiji Seika Pharma Recent Development

Table 128. Tonix Pharmaceuticals Fibromyalgia Treatment Corporation Information

Table 129. Tonix Pharmaceuticals Corporation Information

Table 130. Tonix Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 131. Tonix Pharmaceuticals Main Product

Table 132. Tonix Pharmaceuticals Recent Development

Table 133. Theravance Biopharma Fibromyalgia Treatment Corporation Information

Table 134. Theravance Biopharma Corporation Information

Table 135. Theravance Biopharma Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)

Table 136. Theravance Biopharma Main Product

Table 137. Theravance Biopharma Recent Development

Table 138. Sales Base and Market Concentration Rate of Raw Material

Table 139. Key Suppliers of Raw Materials

Table 140. Fibromyalgia Treatment Distributors List

Table 141. Fibromyalgia Treatment Customers List

Table 142. Market Key Trends

Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 144. Key Challenges

Table 145. Global Fibromyalgia Treatment Sales (KG) Forecast by Type (2021-2026)

Table 146. Global Fibromyalgia Treatment Sales Market Share Forecast by Type (2021-2026)

Table 147. Global Fibromyalgia Treatment Revenue (Million US$) Forecast by Type (2021-2026)

Table 148. Global Fibromyalgia Treatment Revenue (Million US$) Market Share Forecast by Type (2021-2026)

Table 149. Global Fibromyalgia Treatment Sales (KG) Forecast by Application (2021-2026)

Table 150. Global Fibromyalgia Treatment Revenue (Million US$) Forecast by Application (2021-2026)

Table 151. Global Fibromyalgia Treatment Sales (KG) Forecast by Region (2021-2026)

Table 152. Global Fibromyalgia Treatment Sales Market Share Forecast by Region (2021-2026)

Table 153. Global Fibromyalgia Treatment Revenue Forecast by Region (2021-2026) (US$ Million)

Table 154. Global Fibromyalgia Treatment Revenue Market Share Forecast by Region (2021-2026)

Table 155. Research Programs/Design for This Report

Table 156. Key Data Information from Secondary Sources

Table 157. Key Data Information from Primary Sources

List of Figures

Figure 1. Picture of Fibromyalgia Treatment

Figure 2. Global Fibromyalgia Treatment Sales Market Share by Type: 2020 VS 2026

Figure 3. Antidepressants Product Picture

Figure 4. Anticonvulsants Product Picture

Figure 5. Muscle Relaxants Product Picture

Figure 6. Narcotic Analgesics Product Picture

Figure 7. Non-narcotic Analgesics Product Picture

Figure 8. Global Fibromyalgia Treatment Consumption Market Share by Application: 2020 VS 2026

Figure 9. Hospitals Pharmacies

Figure 10. Clinic Pharmacy

Figure 11. Retail Drug Stores

Figure 12. Online Pharmacies

Figure 13. Global Fibromyalgia Treatment Market Size 2015-2026 (US$ Million)

Figure 14. Global Fibromyalgia Treatment Sales Capacity (KG) (2015-2026)

Figure 15. Global Fibromyalgia Treatment Market Size Market Share by Region: 2020 Versus 2026

Figure 16. Fibromyalgia Treatment Sales Share by Manufacturers in 2020

Figure 17. Global Fibromyalgia Treatment Revenue Share by Manufacturers in 2019

Figure 18. The Global 5 and 10 Largest Players: Market Share by Fibromyalgia Treatment Revenue in 2019

Figure 19. Fibromyalgia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 20. Global Fibromyalgia Treatment Sales Market Share by Region (2015-2020)

Figure 21. Global Fibromyalgia Treatment Sales Market Share by Region in 2019

Figure 22. Global Fibromyalgia Treatment Revenue Market Share by Region (2015-2020)

Figure 23. Global Fibromyalgia Treatment Revenue Market Share by Region in 2019

Figure 24. North America Fibromyalgia Treatment Sales Market Share by Country in 2019

Figure 25. North America Fibromyalgia Treatment Revenue Market Share by Country in 2019

Figure 26. U.S. Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 27. U.S. Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 28. Canada Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 29. Canada Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 30. Europe Fibromyalgia Treatment Sales Market Share by Country in 2019

Figure 31. Europe Fibromyalgia Treatment Revenue Market Share by Country in 2019

Figure 32. Germany Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 33. Germany Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 34. France Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 35. France Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 36. U.K. Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 37. U.K. Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 38. Italy Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 39. Italy Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 40. Russia Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 41. Russia Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 42. Asia Pacific Fibromyalgia Treatment Sales Market Share by Region in 2019

Figure 43. Asia Pacific Fibromyalgia Treatment Revenue Market Share by Region in 2019

Figure 44. China Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 45. China Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 46. Japan Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 47. Japan Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 48. South Korea Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 49. South Korea Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 50. India Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 51. India Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 52. Australia Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 53. Australia Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 54. Taiwan Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 55. Taiwan Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 56. Indonesia Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 57. Indonesia Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 58. Thailand Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 59. Thailand Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 60. Malaysia Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 61. Malaysia Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 62. Philippines Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 63. Philippines Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 64. Vietnam Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 65. Vietnam Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 66. Latin America Fibromyalgia Treatment Sales Market Share by Country in 2019

Figure 67. Latin America Fibromyalgia Treatment Revenue Market Share by Country in 2019

Figure 68. Mexico Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 69. Mexico Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. Brazil Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 71. Brazil Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 72. Argentina Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 73. Argentina Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. Middle East and Africa Fibromyalgia Treatment Sales Market Share by Country in 2019

Figure 75. Middle East and Africa Fibromyalgia Treatment Revenue Market Share by Country in 2019

Figure 76. Turkey Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 77. Turkey Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Saudi Arabia Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 79. Saudi Arabia Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 80. U.A.E Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG)

Figure 81. U.A.E Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million)

Figure 82. Sales Market Share of Fibromyalgia Treatment by Type (2015-2020)

Figure 83. Sales Market Share of Fibromyalgia Treatment by Type in 2019

Figure 84. Revenue Share of Fibromyalgia Treatment by Type (2015-2020)

Figure 85. Revenue Market Share of Fibromyalgia Treatment by Type in 2019

Figure 86. Global Fibromyalgia Treatment Sales Growth by Type (2015-2020) (KG)

Figure 87. Global Fibromyalgia Treatment Sales Market Share by Application (2015-2020)

Figure 88. Global Fibromyalgia Treatment Sales Market Share by Application in 2019

Figure 89. Global Revenue Share of Fibromyalgia Treatment by Application (2015-2020)

Figure 90. Global Revenue Share of Fibromyalgia Treatment by Application in 2020

Figure 91. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018

Figure 92. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 93. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018

Figure 94. Allergan Total Revenue (US$ Million): 2019 Compared with 2018

Figure 95. Aptinyx Total Revenue (US$ Million): 2019 Compared with 2018

Figure 96. Prismic Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 97. Innovative Med Concepts Total Revenue (US$ Million): 2019 Compared with 2018

Figure 98. Intec Pharma Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 99. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 100. Savella Total Revenue (US$ Million): 2019 Compared with 2018

Figure 101. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018

Figure 102. Mylan NV Total Revenue (US$ Million): 2019 Compared with 2018

Figure 103. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018

Figure 104. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018

Figure 105. Forest Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 106. Meiji Seika Pharma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 107. Tonix Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 108. Theravance Biopharma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 109. Price Trend of Key Raw Materials

Figure 110. Manufacturing Cost Structure of Fibromyalgia Treatment

Figure 111. Manufacturing Process Analysis of Fibromyalgia Treatment

Figure 112. Fibromyalgia Treatment Industrial Chain Analysis

Figure 113. Channels of Distribution

Figure 114. Distributors Profiles

Figure 115. Porter's Five Forces Analysis

Figure 116. North America Fibromyalgia Treatment Sales (KG) and Growth Rate Forecast (2021-2026)

Figure 117. North America Fibromyalgia Treatment Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 118. Europe Fibromyalgia Treatment Sales (KG) and Growth Rate Forecast (2021-2026)

Figure 119. Europe Fibromyalgia Treatment Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 120. Latin America Fibromyalgia Treatment Sales (KG) and Growth Rate Forecast (2021-2026)

Figure 121. Latin America Fibromyalgia Treatment Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 122. Middle East and Africa Fibromyalgia Treatment Sales (KG) and Growth Rate Forecast (2021-2026)

Figure 123. Middle East and Africa Fibromyalgia Treatment Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 124. Asia Pacific Fibromyalgia Treatment Sales (KG) and Growth Rate Forecast (2021-2026)

Figure 125. Asia Pacific Fibromyalgia Treatment Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 126. Bottom-up and Top-down Approaches for This Report

Figure 127. Data Triangulation

Figure 128. Key Executives Interviewed

Eli Lilly and Company

Pfizer

Novartis AG

Allergan

Aptinyx

Prismic Pharmaceuticals

Innovative Med Concepts

Intec Pharma Ltd.

Astellas Pharma

Savella

Sun Pharmaceutical Industries

Mylan NV

Teva Pharmaceutical Industries

Daiichi Sankyo

Forest Pharmaceuticals

Meiji Seika Pharma

Tonix Pharmaceuticals

Theravance Biopharma

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2262

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase